The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2026

Filed:

Nov. 30, 2021
Applicant:

Medtronic Minimed, Inc., Northridge, CA (US);

Inventors:

Yuxiang Zhong, Arcadia, CA (US);

Anirban Roy, Agoura Hills, CA (US);

Pratik J. Agrawal, Porter Ranch, CA (US);

Ali Dianaty, Porter Ranch, CA (US);

Arthur Mikhno, Princeton, NJ (US);

Shruti Rastogi, Northridge, CA (US);

Taly G. Engel, Los Angeles, CA (US);

Michael P. Stone, Long Beach, CA (US);

Boyi Jiang, Pasadena, CA (US);

Sinu Bessy Abraham, Gallatin, TN (US);

Dae Y. Kang, Los Angeles, CA (US);

Assignee:

MEDTRONIC MINIMED, INC., Northridge, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 5/172 (2006.01); A61M 5/168 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61M 5/16877 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2230/201 (2013.01); A61M 2230/63 (2013.01);
Abstract

A system for monitoring a patient, wherein the system includes one or more processors and a sensor device implemented in circuitry. The system is configured to measure, using the sensor device, a blood glucose status of the patient, and determine, using the one or more processors, an initial insulin dose for the patient based on the blood glucose status of the patient. The system is further configured to optimize the initial insulin dose for the patient, based at least in part on a correction factor, to create an optimized insulin dose for the patient. The system is configured to facilitate therapy, using the one or more processors, based on the optimized insulin dose.


Find Patent Forward Citations

Loading…